The healthcare landscape is seeing a change with the emergence of GLP-1 transdermal systems . These exciting formulations offer a possible approach to providing glucagon-like peptide-1 therapies for individuals living with the disease . Instead of needles, a easy-to-use patch placed to the area could administer a steady quantity of the substance, p